During his time at Peptonic,
"We are grateful for Erik's and Dan's efforts and dedication during their time at Peptonic. Their contributions have been significant for the company, and we wish them both the best in their future endeavors," says
These positions will not be filled at this time.
For further information, please contact:
Anna Linton, CEO
Email: anna.linton@peptonicmedical.se
Phone: +46 70-244 92 07
About Peptonic
Central to the growth strategy is the geographical expansion of VagiVital and Verniva through local partners. Peptonic Medical also intends to continuously broaden the company's product portfolio through acquisitions and the development of innovative and competitive products in-house. The company's mousse-based drug delivery technology, Venerol, and the gel base in VagiVital create favorable conditions for expanding the portfolio.
The company is headquartered in Stockholm, Sweden, and has subsidiaries
https://news.cision.com/peptonic-medical-ab/r/peptonic-medical-ab-announces-organizational-changes,c3984897
(c) 2024 Cision. All rights reserved., source